BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33367573)

  • 1. Clinical Characteristics and Outcomes of Breakthrough Candidemia in 71 Hematologic Malignancy Patients and/or Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Single-center Retrospective Study From China, 2011-2018.
    Chen XC; Xu J; Wu DP
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S394-S399. PubMed ID: 33367573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
    Kimura M; Araoka H; Yamamoto H; Asano-Mori Y; Nakamura S; Yamagoe S; Ohno H; Miyazaki Y; Abe M; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Uchida N; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020.
    Nishida R; Eriguchi Y; Miyake N; Nagasaki Y; Yonekawa A; Mori Y; Kato K; Akashi K; Shimono N
    Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37312399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
    Li Y; Du M; Chen LA; Liu Y; Liang Z
    Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.
    Pagano L; Dragonetti G; Cattaneo C; Marchesi F; Veggia B; Busca A; Candoni A; Prezioso L; Criscuolo M; Cesaro S; Delia M; Fanci R; Stanzani M; Ferrari A; Martino B; Melillo L; Nadali G; Simonetti E; Ballanti S; Picardi M; Castagnola C; Decembrino N; Gazzola M; Fracchiolla NS; Mancini V; Nosari A; Principe MID; Aversa F; Tumbarello M;
    Haematologica; 2017 Oct; 102(10):e407-e410. PubMed ID: 28729301
    [No Abstract]   [Full Text] [Related]  

  • 7. [Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation].
    Okinaka K
    Med Mycol J; 2016; 57(3):J117-23. PubMed ID: 27581780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes.
    Lai MY; Hsu JF; Chu SM; Wu IH; Huang HR; Lin CC; Lee IT; Chiang MC; Fu RH; Tsai MH
    Future Microbiol; 2017 Jun; 12():695-705. PubMed ID: 28326813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
    Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
    Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
    Chen PY; Chuang YC; Wang JT; Sheng WH; Yu CJ; Chu CC; Hsueh PR; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2014 Apr; 47(2):95-103. PubMed ID: 23063082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment for candidemia in patients with blood system tumors].
    Kliasova GA; Blokhina EV; Gracheva AN; Kravchenko SK; Parovichnikova EN; Galstian GM
    Ter Arkh; 2013; 85(11):47-53. PubMed ID: 24432599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies].
    Klyasova GA; Malchikova AO; Tandilova KS; Blohina EV; Parovichnikova EN; Kravchenko SK; Savchenko VG
    Ter Arkh; 2019 Aug; 91(8):84-92. PubMed ID: 32598758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients.
    Zhang W; Song X; Wu H; Zheng R
    BMC Infect Dis; 2020 Jul; 20(1):506. PubMed ID: 32660641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.
    Tsai MH; Hsu JF; Chu SM; Chang PJ; Lai MY; Wu IH; Huang HR; Chiang MC; Fu RH; Lu JJ
    Sci Rep; 2017 Apr; 7(1):1083. PubMed ID: 28439070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Candidemia in Solid-Organ Transplant Recipients.
    Sari N; Yanik Yalçin T; Erol Ç; Kurt Azap Ö; Arslan H; Karakaya E; Sezgin A; Haberal M
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):160-166. PubMed ID: 38385390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.